Income Statement Balance Sheet Cash Flow Statement
Annual Financials for ADMA Biologics Inc.
Fiscal year is January-December. All values USD millions. 2011 2012 2013 5-year trend
Sales/Revenue - - 761,042 1.12M 3.07M
Cost of Goods Sold (COGS) incl. D&A - - 2.02M 669,056 4.44M
COGS excluding D&A - - 1.8M 486,967 4.23M
Depreciation & Amortization Expense - - 219,552 182,089 210,633
Depreciation - - - - 210,633
Amortization of Intangibles - - - - 0
Gross Income - - (1.26M) 449,062 (1.37M)
2011 2012 2013 5-year trend
SG&A Expense - - 1.43M 8.36M 13.67M
Research & Development - - 0 3.47M 9.3M
Other SG&A - - 1.43M 4.89M 4.37M
Other Operating Expense - - 0 0 0
Unusual Expense - - - 0 (43,290)
EBIT after Unusual Expense - - - 0 43,290
Non Operating Income/Expense - - (1.93M) 0 82,497
Non-Operating Interest Income - - 1,689 20,924 7,623
Equity in Affiliates (Pretax) - - 0 - 0
Interest Expense - - 1.6M 30,683 618,225
Gross Interest Expense - - 1.6M 30,683 618,225
Interest Capitalized - - 0 0 0
Pretax Income - - (6.22M) (7.92M) (15.53M)
Income Tax - - (320,765) (617,615) 0
Income Tax - Current Domestic - - (320,765) - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates - - 0 0 0
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income - - (5.9M) (7.3M) (15.53M)
Minority Interest Expense - - 0 0 0
Net Income - - (5.9M) (7.3M) (15.53M)
Extraordinaries & Discontinued Operations - - 0 0 0
Extra Items & Gain/Loss Sale Of Assets - - 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations - - - 0 0
Net Income After Extraordinaries - - (5.9M) (7.3M) (15.53M)
Preferred Dividends - - 0 0 0
Net Income Available to Common - - (5.9M) (7.3M) (15.53M)
EPS (Basic) - - (16.72) (1.76) (2.38)
Basic Shares Outstanding - - 353,098 4.15M 6.53M
EPS (Diluted) - - (16.72) (1.76) (2.38)
Diluted Shares Outstanding - - 353,098 4.15M 6.53M
EBITDA - - (2.47M) (7.73M) (14.83M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.